Evidence map›Paper›PMID 35811886›Full record

ArticleACS omega2022

Osteogenic Effect of Fisetin Doping in Bioactive Glass/Poly(caprolactone) Hybrid Scaffolds.

Henri Granel, Cédric Bossard, Anne-Margaux Collignon, Fabien Wauquier, Julie Lesieur, Gael Y Rochefort, Edouard Jallot, Jonathan Lao, Yohann Wittrant

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Flavonoid-Loaded Biomaterials in Bone Defect Repair.Molecules (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Henri GranelINRAE, Human Nutrition Unit (UNH), ECREIN Team, TSA 50400, 28 Place Henri Dunant, Clermont-Ferrand, Auvergne-Rhone-Alpes 63001, France.
Cédric BossardUniversité Clermont Auvergne, Laboratoire De Physique De Clermont Ferrand, 4 Avenue Blaise Pascal, Clermont-Ferrand, Auvergne-Rhône-Alpes 63001, France.ORCID https://orcid.org/0000-0002-7892-1382
Anne-Margaux CollignonDescartes University of Paris Faculty of Dental Surgery, Laboratoires Pathologies, Imagerie et Biothérapies Orofaciales,1 Rue Maurice Arnoux, Montrouge, Île-De-France 92120, France.
Fabien WauquierINRAE, Human Nutrition Unit (UNH), ECREIN Team, TSA 50400, 28 Place Henri Dunant, Clermont-Ferrand, Auvergne-Rhone-Alpes 63001, France.
Julie LesieurDescartes University of Paris Faculty of Dental Surgery, Laboratoires Pathologies, Imagerie et Biothérapies Orofaciales,1 Rue Maurice Arnoux, Montrouge, Île-De-France 92120, France.
Gael Y RochefortDescartes University of Paris Faculty of Dental Surgery, Laboratoires Pathologies, Imagerie et Biothérapies Orofaciales,1 Rue Maurice Arnoux, Montrouge, Île-De-France 92120, France.
Edouard JallotUniversité Clermont Auvergne, Laboratoire De Physique De Clermont Ferrand, 4 Avenue Blaise Pascal, Clermont-Ferrand, Auvergne-Rhône-Alpes 63001, France.
Jonathan LaoUniversité Clermont Auvergne, Laboratoire De Physique De Clermont Ferrand, 4 Avenue Blaise Pascal, Clermont-Ferrand, Auvergne-Rhône-Alpes 63001, France.
Yohann WittrantINRAE, Human Nutrition Unit (UNH), ECREIN Team, TSA 50400, 28 Place Henri Dunant, Clermont-Ferrand, Auvergne-Rhone-Alpes 63001, France.ORCID https://orcid.org/0000-0003-3811-8859
Laboratory Orofacial Pathologies, Imaging and Biotherapies · FRUnité de Nutrition Humaine · FRUniversité Clermont Auvergne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treating large bone defects or fragile patients may require enhancing the bone regeneration rate to overcome a weak contribution from the body. This work investigates the osteogenic potential of nutrient fisetin, a flavonoid found in fruits and vegetables, as a doping agent inside the structure of a SiO

Identifiers

PMID35811886
PMCPMC9260777
OpenAlexW4283220732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.